Filing Details
- Accession Number:
- 0001127602-13-017263
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-17 12:35:21
- Reporting Period:
- 2012-08-01
- Filing Date:
- 2013-05-17
- Accepted Time:
- 2013-05-17 12:35:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1456336 | Gregory Stea | 65 Hayden Avenue Lexington MA 02421 | Svp, Commercial Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-08-01 | 136 | $42.90 | 0 | No | 4 | S | Indirect | 401(k) Plan |
Common Stock | Acquisiton | 2013-05-15 | 800 | $0.00 | 14,457 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-16 | 268 | $47.88 | 14,189 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | 401(k) Plan |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2013-05-15 | 800 | $0.00 | 800 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-05-15 | No | 4 | M | Direct |
Footnotes
- Sold pursuant to a Rule 10(b)5-1 Plan.
- Shares were sold to cover tax obligations incurred in connection with the vesting of Restricted Stock Units.
- This transaction was executed in multiple trades at prices ranging from $47.6001 to $48.2650. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to privde upon request to the SEC staff, the issuer or a secruity holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration.
- The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire.